Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.

KIF2C P53 signaling pathway cervical cancer molecularly targeted therapy pan-cancer analysis

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 29 09 2021
accepted: 21 12 2021
entrez: 14 2 2022
pubmed: 15 2 2022
medline: 15 2 2022
Statut: epublish

Résumé

Kinesin family member 2C (

Identifiants

pubmed: 35153749
doi: 10.3389/fphar.2021.785981
pii: 785981
pmc: PMC8828917
doi:

Types de publication

Journal Article

Langues

eng

Pagination

785981

Informations de copyright

Copyright © 2022 Yang, Wu, Yang, Jeong, Zhu, Lu, Wang, Wang, Wang, Shen and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102
pubmed: 28407145
Oncotarget. 2015 Sep 29;6(29):28371-88
pubmed: 26318295
BMC Med Genomics. 2009 Apr 24;2:18
pubmed: 19393097
Nature. 2009 Oct 1;461(7264):614-20
pubmed: 19759537
Cell Cycle. 2008 Jul 15;7(14):2146-56
pubmed: 18635958
Cancer Res. 2015 Dec 1;75(23):5001-7
pubmed: 26573797
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Br J Cancer. 2007 Aug 20;97(4):543-9
pubmed: 17653072
Cell Biochem Funct. 2019 Aug;37(6):424-431
pubmed: 31328811
Cancer Biomark. 2019;24(3):371-382
pubmed: 30883337
Nat Rev Cancer. 2020 Aug;20(8):471-480
pubmed: 32404993
Lancet. 2019 Mar 9;393(10175):969-970
pubmed: 30860036
Crit Rev Biochem Mol Biol. 2015 Jul-Aug;51(4):228-45
pubmed: 27146484
Front Immunol. 2021 Jun 11;12:665407
pubmed: 34177903
Cancer Sci. 2008 Jan;99(1):62-70
pubmed: 17944972
Lancet. 2020 Feb 22;395(10224):575-590
pubmed: 32007141
Clin Cancer Res. 2004 Dec 15;10(24):8465-71
pubmed: 15623626
Aging (Albany NY). 2020 Apr 19;12(8):6865-6879
pubmed: 32305958
Lancet Oncol. 2021 Jan;22(1):20-21
pubmed: 33248466
Cell Cycle. 2008 Oct;7(20):3187-93
pubmed: 18843200
Genome Res. 2014 May;24(5):743-50
pubmed: 24782321
Cancers (Basel). 2018 May 05;10(5):
pubmed: 29734756
Cancer Cell Int. 2020 Apr 15;20:123
pubmed: 32322170
Int J Mol Med. 2017 Feb;39(2):446-452
pubmed: 28035359
Cell. 2006 Dec 1;127(5):969-82
pubmed: 17129782
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
J Mol Cell Biol. 2019 Mar 1;11(3):245-254
pubmed: 30689917
Nat Commun. 2019 Dec 12;10(1):5679
pubmed: 31831737
J Cancer. 2019 Aug 28;10(21):5212-5222
pubmed: 31602272
Protein Cell. 2021 Oct;12(10):788-809
pubmed: 32748349
Biomed Pharmacother. 2020 May;125:109948
pubmed: 32106364
Cancers (Basel). 2020 Nov 13;12(11):
pubmed: 33202864
Nucleic Acids Res. 2018 Jan 4;46(D1):D956-D963
pubmed: 29136207
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514
pubmed: 32442275
CA Cancer J Clin. 2021 Nov;71(6):466-487
pubmed: 34545941

Auteurs

Jing Yang (J)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zimeng Wu (Z)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Li Yang (L)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Henan International Joint Laboratory of Ovarian Malignancies, Zhengzhou, China.
Zhengzhou Key Laboratory of Endometrial Disease Prevention and Treatment, Zhengzhou, China.

Ji-Hak Jeong (JH)

Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, South Korea.

Yuanhang Zhu (Y)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Jie Lu (J)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Baojin Wang (B)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Henan International Joint Laboratory of Ovarian Malignancies, Zhengzhou, China.

Nannan Wang (N)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Yan Wang (Y)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Ke Shen (K)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Ruiqing Li (R)

Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Classifications MeSH